Nevro investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of nevro corp. - nvro

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of nevro corp. (nyse: nvro) to globus medical, inc. (nyse: gmed). under the terms of the proposed transaction, shareholders of nevro will receive $5.85 in cash for each share of nevro that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the.
GM Ratings Summary
GM Quant Ranking